Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Exopharm Limited, Melbourne, Australia.
Cytotherapy. 2022 Jun;24(6):619-628. doi: 10.1016/j.jcyt.2022.02.003. Epub 2022 Mar 18.
BACKGROUND AIMS: Extracellular vesicles (EVs) are involved in mediating intercellular communication processes. An important goal within the EV field is the study of the biodistribution of EVs and the identification of their target cells. Considering that EV uptake is assumed to be important for EVs in mediating intercellular communication processes, labeling with fluorescent dyes has emerged as a broadly distributed strategy for the identification of EV target cells and tissues. However, the accuracy and specificity of commonly utilized labeling dyes have not been sufficiently analyzed. METHODS: By combining recent advances in imaging flow cytometry for the phenotypic analysis of single EVs and aiming to identify target cells for EVs within therapeutically relevant mesenchymal stromal cell (MSC)-EV preparations, the authors explored the EV labeling efficacy of various fluorescent dyes, specifically carboxyfluorescein diacetate succinimidyl ester, calcein AM, PKH67, BODIPY TR ceramide (Thermo Fisher Scientific, Darmstadt, Germany) and a novel lipid dye called Exoria (Exopharm Limited, Melbourne, Australia). RESULTS: The authors' analyses qualified Exoria as the only dye that specifically labeled EVs within the MSC-EV preparations. Furthermore, the authors demonstrated that Exoria labeling did not interfere with the immunomodulatory properties of the MSC-EV preparations as tested in a multi-donor mixed lymphocyte reaction assay. Within this assay, labeled EVs were differentially taken up by different immune cell types. CONCLUSIONS: Overall, the results qualify Exoria as an appropriate dye for the labeling of EVs derived from the authors' MSC-EV preparations. This study also demonstrates the need for the development of next-generation EV characterization tools that are able to localize and confirm the specificity of EV labeling.
背景目的:细胞外囊泡 (EVs) 参与介导细胞间通讯过程。EV 领域的一个重要目标是研究 EV 的生物分布及其靶细胞的鉴定。考虑到 EV 的摄取对于 EV 介导细胞间通讯过程很重要,因此用荧光染料进行标记已成为鉴定 EV 靶细胞和组织的广泛应用策略。然而,常用标记染料的准确性和特异性尚未得到充分分析。
方法:作者通过结合成像流式细胞术对单个 EV 的表型分析的最新进展,并旨在鉴定治疗相关间充质基质细胞 (MSC)-EV 制剂中 EV 的靶细胞,探索了各种荧光染料的 EV 标记效率,特别是羧基荧光素二乙酸琥珀酰亚胺酯、钙黄素 AM、PKH67、BODIPY TR 神经酰胺(Thermo Fisher Scientific,达姆施塔特,德国)和一种新型脂质染料 Exoria(Exopharm Limited,墨尔本,澳大利亚)。
结果:作者的分析将 Exoria 鉴定为唯一一种在 MSC-EV 制剂中特异性标记 EV 的染料。此外,作者证明 Exoria 标记不会干扰 MSC-EV 制剂的免疫调节特性,如在多供体混合淋巴细胞反应测定中所测试的那样。在该测定中,标记的 EV 被不同的免疫细胞类型摄取。
结论:总体而言,结果将 Exoria 鉴定为标记作者 MSC-EV 制剂衍生的 EV 的合适染料。本研究还表明需要开发能够定位和确认 EV 标记特异性的下一代 EV 特征分析工具。
Sci Rep. 2017-5-12
Methods Enzymol. 2020
Methods Enzymol. 2020
J Extracell Vesicles. 2025-1
Extracell Vesicles Circ Nucl Acids. 2022-3-16
Extracell Vesicles Circ Nucl Acids. 2023-12-7
Nat Nanotechnol. 2025-1
Front Bioeng Biotechnol. 2024-9-18